Patents by Inventor Qingjie Zhao

Qingjie Zhao has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PRC1 INHIBITORS AND METHODS OF TREATMENT THEREWITH
    Publication number: 20230118233
    Abstract: Provided herein are small molecule inhibitors of Polycomb Repressive Complex 1 (PRC1) activity, and methods of use thereof for the treatment of disease, including leukemia and other cancers, as well as other diseases dependent on the activity of PRC1.
    Type: Application
    Filed: April 28, 2022
    Publication date: April 20, 2023
    Inventors: Tomasz Cierpicki, Jolanta Grembecka, Weijiang Ying, Yiwu Yao, Felicia Gray, Qingjie Zhao
  • PRC1 inhibitors and methods of treatment therewith
    Patent number: 11319302
    Abstract: Provided herein are small molecule inhibitors of Polycomb Repressive Complex 1 (PRC1) activity, and methods of use thereof for the treatment of disease, including leukemia and other cancers, as well as other diseases dependent on the activity of PRC1.
    Type: Grant
    Filed: June 7, 2019
    Date of Patent: May 3, 2022
    Assignee: The Regents of the University of Michigan
    Inventors: Tomasz Cierpicki, Jolanta Grembecka, Weijiang Ying, Yiwu Yao, Felicia Gray, Qingjie Zhao
  • PRC1 INHIBITORS AND METHODS OF TREATMENT THEREWITH
    Publication number: 20200039963
    Abstract: Provided herein are small molecule inhibitors of Polycomb Repressive Complex 1 (PRC1) activity, and methods of use thereof for the treatment of disease, including leukemia and other cancers, as well as other diseases dependent on the activity of PRC1.
    Type: Application
    Filed: June 7, 2019
    Publication date: February 6, 2020
    Inventors: Tomasz Cierpicki, Jolanta Grembecka, Weijiang Ying, Yiwu Yao, Felicia Gray, Qingjie Zhao